Molecular Mechanisms of Vasa Vasorum Angiogenesis and Dysregulation of Vascular Smooth Muscle Cell Differentiation

血管血管生成和血管平滑肌细胞分化失调的分子机制

基本信息

  • 批准号:
    16390216
  • 负责人:
  • 金额:
    $ 9.09万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

Thickened atherosclerotic plaques are prone to be hypoxic because of poor perfusion. In this study, we tested the hypothesis that hypoxia produces reactive oxygen species (ROS) and activates c-Src tyrosine kinase in vascular smooth muscle cells (VSMC). Treatment of VSMCs with redox-sensitive probes, dihydroethidium and 2',7'-dihydrodichlorofluorescein diacetate, revealed that hypoxia increased intracellular superoxide anion and hydrogen peroxide (H_2O_2). Northern blot analysis showed that hypoxia-induced PAI-1 and VEGF genes expression was significantly inhibited by c-Src inhibitor PP1. Western blot analysis showed that hypoxia rapidly elicited tyrosine phosphorylation of c-Src. Induction of the PAI-1 and VEGF genes expression was significantly attenuated in c-Src-, Yes-, and Fyn-negative cells as compared with c-Src-overexpressing cells. Hypoxia-inducible HIF-1α protein expression was significantly attenuated by PP1, diphenyleneiodonium (DPI), and N-acetyl 1-cysteine. Rotenone and an … More timycin A, which inhibit the mitochondrial electron transport chain, abolished the HIF-1α induction by hypoxia. Treatment of VSMC with H_2O_2 induced HIF-1α protein even under normoxia. These results suggest that ROS and c-Src play a critical role in hypoxia-induced HIF-1α protein and PAI-1 and VEGF gene expression in VSMC. Our data also demonstrate that mitochondria act as the O_2 sensor mediating c-Src phosphorylation during hypoxia.In addition, we determined the role of Notch target gene HERP1 in the regulation of phenotypic modulation of vascular SMC. The present study characterizes the expression of HERP1 in normal and diseased vessels, and tests the hypothesis that HERP1 inhibits SRF/myocardin-dependent SMC gene expression. Immunohistochemistry revealed that HERP1 and myocardin expression was localized to SMC of the neointima after balloon injury of rat aorta and in human coronary atherosclerotic lesions. Expression of both HERP1 and myocardin was markedly elevated in cultured VSMC compared with medial SMC. Overexpression of HERP1 dramatically inhibited the myocarin-induced SMC-marker gene expression. Immunoprecipitation assays showed that HERP1 physically interacts with SRF. Thus, we conclude that HERP1 may play a role in promoting the phenotypic modulation of VSMC during vascular injury and atherosclerotic process by interfering with SRF binding to CArG box through physical association between HERP1 and SRF. Less
增厚的动脉粥样硬化斑块由于灌注不良而容易出现低氧。在这项研究中,我们检验了低氧产生活性氧(ROS)并激活血管平滑肌细胞(VSMC)中的C-SRC酪氨酸激酶的假设。用氧化还原敏感的探针,二氢二硫二二苯甲酸和7'-二氢二氯氟乙酸酯二乙酸酯处理VSMC,发现缺氧增加了细胞内的超氧阴离子和过氧化氢(H_2O_2)。北印迹分析表明,缺氧诱导的PAI-1和VEGF基因表达受到C-SRC抑制剂PP1的显着抑制。蛋白质印迹分析表明,缺氧迅速引起C-SRC的酪氨酸磷酸化。与C-SRC过表达的细胞相比,在C-SRC-,YES和FYN阴性细胞中,PAI-1和VEGF基因表达的诱导显着减弱。 PP1,二苯基二元(DPI)和N-乙酰基1-半胱氨酸可显着减弱缺氧诱导的HIF-1α蛋白表达。烤面包酮和一个……更多的蛋白霉素A,抑制线粒体电子传输链,通过缺氧废除了HIF-1α蛋白。使用H_2O_2处理VSMC,即使在常氧下也诱导了HIF-1α蛋白。这些结果表明,ROS和C-SRC在VSMC中缺氧诱导的HIF-1α蛋白以及PAI-1和VEGF基因表达中起关键作用。我们的数据还表明,线粒体充当缺氧期间介导C-SRC磷酸化的O_2传感器。此外,我们确定了Notch靶基因HERP1在调节血管SMC表型调节中的作用。本研究表征了HERP1在正常和解散的血管中的表达,并检验了HERP1抑制SRF/肌动蛋白依赖性SMC基因表达的假设。免疫组织化学表明,在大鼠主动脉和人类冠状动脉粥样硬化病变中,HERP1和心肌表达位于新内膜的SMC中。与媒体SMC相比,在培养的VSMC中,HERP1和心肌的表达显着升高。 HERP1的过表达急剧抑制了肌醇诱导的SMC标记基因表达。免疫沉淀测定表明HERP1与SRF物理相互作用。这就是我们包括HERP1通过通过HERP1和SRF之间的物理关联来干扰SRF结合在血管损伤和动脉粥样硬化过程中在血管损伤和动脉粥样硬化过程中的表型调节中发挥作用。较少的

项目成果

期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
c-Src and hydrogen peroxide mediate transforming growth factor-betal-induced smooth muscle cell-gene expression in 1OT1/2 cells
c-Src 和过氧化氢介导 1OT1/2 细胞中转化生长因子-β-诱导的平滑肌细胞基因表达
Homeobox protein Hex facilitates serum responsive factor-
同源盒蛋白 Hex 促进血清反应因子-
c-Src and hydrogen peroxide mediate transforming growth factor-betal-induced smooth muscle cell-gene expression in 10T1/2 cells
c-Src和过氧化氢介导10T1/2细胞中转化生长因子-β诱导的平滑肌细胞基因表达
Mitochondrial reactive oxygen species and c-Src plaz a critical role in hypoxic response in vascular smooth muscle cells
线粒体活性氧和 c-Src plaz 在血管平滑肌细胞缺氧反应中发挥关键作用
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sato H;Sato M;et al.
  • 通讯作者:
    et al.
Visible light exposure induces VEGF gene expression through activation of retinoic acid receptor-alpha in retinoblastoma Y79 cells.
可见光照射通过激活视网膜母细胞瘤 Y79 细胞中的视黄酸受体-α 来诱导 VEGF 基因表达。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KURABAYASHI Masahiko其他文献

KURABAYASHI Masahiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KURABAYASHI Masahiko', 18)}}的其他基金

Molecular mechanisms of the association between .t2DM and Tskotudo
.t2DM 和 Tskotudo 关联的分子机制
  • 批准号:
    24390194
  • 财政年份:
    2012
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanism of vascular calcification in chronic kidney disease
慢性肾脏病血管钙化的分子机制
  • 批准号:
    20390216
  • 财政年份:
    2008
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular Mechanism of Vascular Calcification
血管钙化的分子机制
  • 批准号:
    18390227
  • 财政年份:
    2006
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional Analysis of p53-Regulatory Protein CARP in Atherosclerosis
p53 调节蛋白 CARP 在动脉粥样硬化中的功能分析
  • 批准号:
    14370218
  • 财政年份:
    2002
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Transcriptional Regulation of the cardiovaocular genes in respone to stress
应激反应中心血管基因的转录调控
  • 批准号:
    11470156
  • 财政年份:
    1999
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Molecular Mechanisms of Genetic Response of Myocardial Cells to Cytotoxic Stress
心肌细胞对细胞毒性应激的遗传反应的分子机制
  • 批准号:
    09470161
  • 财政年份:
    1997
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of Strategy of Molecular Cloning of Cardiac-Specific-Gene by use of Adriamycin
阿霉素心脏特异性基因分子克隆策略的开发
  • 批准号:
    08557048
  • 财政年份:
    1996
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)

相似国自然基金

肠道真菌通过肠缺氧诱导因子HIF-2α促进动脉粥样硬化发病的作用机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
肠道真菌通过肠缺氧诱导因子HIF-2α促进动脉粥样硬化发病的作用机制研究
  • 批准号:
    32271232
  • 批准年份:
    2022
  • 资助金额:
    54.00 万元
  • 项目类别:
    面上项目
间歇缺氧通过Smad3/PAPD5轴调控内皮祖细胞衰老在动脉粥样硬化性疾病发生中的机制研究
  • 批准号:
    82270099
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
CCL5/CCR5介导巨噬细胞在间歇性缺氧所致动脉粥样硬化钙化中的作用与机制
  • 批准号:
    82200495
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
CCL5/CCR5介导巨噬细胞在间歇性缺氧所致动脉粥样硬化钙化中的作用与机制
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
  • 批准号:
    10585070
  • 财政年份:
    2023
  • 资助金额:
    $ 9.09万
  • 项目类别:
Novel Coronary Artery Vasodilator Development
新型冠状动脉血管扩张剂的开发
  • 批准号:
    10758940
  • 财政年份:
    2023
  • 资助金额:
    $ 9.09万
  • 项目类别:
Branched-chain Keto-acids and Aerobic Glycolysis in Vascular Smooth Muscle Cells
血管平滑肌细胞中的支链酮酸和有氧糖酵解
  • 批准号:
    10731096
  • 财政年份:
    2023
  • 资助金额:
    $ 9.09万
  • 项目类别:
Novel vascular smooth muscle cell progenitors in development and disease
发育和疾病中的新型血管平滑肌细胞祖细胞
  • 批准号:
    10670304
  • 财政年份:
    2020
  • 资助金额:
    $ 9.09万
  • 项目类别:
Novel vascular smooth muscle cell progenitors in development and disease
发育和疾病中的新型血管平滑肌细胞祖细胞
  • 批准号:
    9893632
  • 财政年份:
    2020
  • 资助金额:
    $ 9.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了